<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72012">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01680042</url>
  </required_header>
  <id_info>
    <org_study_id>Merck-023</org_study_id>
    <nct_id>NCT01680042</nct_id>
  </id_info>
  <brief_title>Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy</brief_title>
  <official_title>Phase 1 Study of Phenytoin Mucoadhesive Paste for Wound Healing After Oral Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti Medical University</source>
  <oversight_info>
    <authority>Iran: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      several studies have investigated healing effect of phenytoin.In this study we investigate
      healing effect of phenytoin mucoadhesive paste comparing to the  usual mucoadhesive paste
      after oral biopsy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>healing biopsy wound</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>patient recieves phenytoin mucoadhesive paste after oral biopsy and the diameter of inflammatory halo is determined in 1,3,5and the 7th days.pain measurment is also assesed by VAS score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Wound Healing</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>phenytoin paste</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>this group receives phenytoin paste after oral biopsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual mucoadhesive paste</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>this group receives the usual mucoadhesive paste without phenytoin after oral biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenytoin paste</intervention_name>
    <arm_group_label>phenytoin paste</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>usual mucoadhesive paste</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergone oral biopsy

        Exclusion Criteria:

          -  systemic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>somayeh alirezaei, DDS</last_name>
    <phone>09123705943</phone>
    <email>dr.somayehalirezaei@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shahid Beheshti Medical University</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>somayeh alirezaei, DDS</last_name>
      <phone>09123705943</phone>
      <email>dr.somayehalirezaei@gmail.com</email>
    </contact>
    <investigator>
      <last_name>somayeh alirezaei, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaheed Beheshti University</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>somayeh alirezaei, resident</last_name>
      <phone>09190129151</phone>
      <email>somayeh_alirezaei_dentist@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>somayeh alirezaei, resident</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 1, 2012</lastchanged_date>
  <firstreceived_date>September 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shaheed Beheshti Medical University</investigator_affiliation>
    <investigator_full_name>somayeh alirezaei</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>inflammatory halo</keyword>
  <keyword>VAS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Phenytoin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
